Year in review in Intensive Care Medicine 2014: III. Severe infections, septic shock, healthcare-associated infections, highly resistant bacteria, invasive fungal infections, severe viral infections, Ebola virus disease and paediatrics

Intensive Care Medicine

Volumn 41, Issue 4, 2015, Pages 575-588

  Timsit, Jean François ^a   Perner, Anders ^b   Bakker, Jan ^c   Bassetti, Matteo ^d   Benoit, Dominique ^e   Cecconi, Maurizio ^f   Randall Curtis, J ^g   Doig, Gordon S ^h   Herridge, Margaret ⁱ   Jaber, Samir ^j   Joannidis, Michael ^k   Papazian, Laurent ^l   Peters, Mark J ^m   Singer, Pierre ⁿ   Smith, Martin ^o   Soares, Marcio ^p   Torres, Antoni ^q   Vieillard Baron, Antoine ^r   Citerio, Giuseppe ^s   Azoulay, Elie ^t  

^a UNIVERSITÉ PARIS DIDEROT   (France)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^e GHENT UNIVERSITY HOSPITAL   (Belgium)

^f ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^g UNIVERSITY OF WASHINGTON   (United States)

^h UNIVERSITY OF SYDNEY   (Australia)

ⁱ UNIVERSITY OF TORONTO   (Canada)

^j HÔPITAL SAINT ELOI   (France)

^k INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^l AIX MARSEILLE UNIVERSITY   (France)

^m UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁿ TEL AVIV UNIVERSITY   (Israel)

^o NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^p D OR INSTITUTE FOR RESEARCH AND EDUCATION IDOR   (Brazil)

^q HOSPITAL CLÍNIC   (Spain)

^r HÔPITAL AMBROISE PARÉ   (France)

^s UNIVERSITY OF MILANO BICOCCA   (Italy)

^t SAINT LOUIS HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHILD; CRITICAL ILLNESS; CROSS INFECTION; EBOLA HEMORRHAGIC FEVER; HUMAN; INFECTION; INTENSIVE CARE UNIT; LUNG MYCOSIS; PEDIATRICS; SEPTIC SHOCK; VENTILATOR ASSOCIATED PNEUMONIA;

CHILD; CRITICAL ILLNESS; CROSS INFECTION; HEMORRHAGIC FEVER, EBOLA; HUMANS; INFECTION; INTENSIVE CARE UNITS; LUNG DISEASES, FUNGAL; PEDIATRICS; PNEUMONIA, VENTILATOR-ASSOCIATED; SHOCK, SEPTIC;

EID: 84940001374     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-015-3755-8     Document Type: Review

References (78)

1. Antonelli M, Levy M, Andrews PJD et al (2007) Hemodynamic monitoring in shock and implications for management. International Consensus Conference, Paris, France, 27–28 April 2006. Intensive Care Med 33:575–590. doi:10.1007/s00134-007-0531-4
2. Rochwerg B, Alhazzani W, Jaeschke R (2014) Clinical meaning of the GRADE rules. Intensive Care Med 40:877–879. doi:10.1007/s00134-014-3273-0
3. Cecconi M, De Backer D, Antonelli M et al (2014) Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med 40:1795–1815. doi:10.1007/s00134-014-3525-z
4. Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39:165–228. doi:10.1007/s00134-012-2769-8
5. Legrand M, Dupuis C, Simon C et al (2013) Association between systemic hemodynamics and septic acute kidney injury in critically ill patients: a retrospective observational study. Crit Care Lond Engl 17:R278. doi:10.1186/cc13133
6. Boyd JH, Forbes J, Nakada T et al (2011) Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med 39:259–265. doi:10.1097/CCM.0b013e3181feeb15
7. Levy MM, Rhodes A, Phillips GS et al (2014) Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5 year study. Intensive Care Med 40:1623–1633. doi:10.1007/s00134-014-3496-0
8. Bakker J, Perner A, Timsit J-F (2015) Evaluation of 7.5 years of Surviving Sepsis Campaign guidelines. Intensive Care Med 41:151–153. doi:10.1007/s00134-014-3526-y
9. Berlin DA, Bakker J (2014) Understanding venous return. Intensive Care Med 40:1564–1566. doi:10.1007/s00134-014-3379-4
10. Perner A, De Backer D (2014) Understanding hypovolaemia. Intensive Care Med 40:613–615. doi:10.1007/s00134-014-3223-x
11. Vieillard-Baron A, Cecconi M (2014) Understanding cardiac failure in sepsis. Intensive Care Med 40:1560–1563. doi:10.1007/s00134-014-3367-8
12. Lima A, van Genderen ME, Klijn E et al (2012) Peripheral vasoconstriction influences thenar oxygen saturation as measured by near-infrared spectroscopy. Intensive Care Med 38:606–611. doi:10.1007/s00134-012-2486-3
13. Ait-Oufella H, Lemoinne S, Boelle PY et al (2011) Mottling score predicts survival in septic shock. Intensive Care Med 37:801–807. doi:10.1007/s00134-011-2163-y
14. Ait-Oufella H, Joffre J, Boelle PY et al (2012) Knee area tissue oxygen saturation is predictive of 14-day mortality in septic shock. Intensive Care Med 38:976–983. doi:10.1007/s00134-012-2555-7
15. Ait-Oufella H, Bige N, Boelle PY et al (2014) Capillary refill time exploration during septic shock. Intensive Care Med 40:958–964. doi:10.1007/s00134-014-3326-4
16. Van Genderen ME, Paauwe J, de Jonge J et al (2014) Clinical assessment of peripheral perfusion to predict postoperative complications after major abdominal surgery early: a prospective observational study in adults. Crit Care Lond Engl 18:R114. doi:10.1186/cc13905
17. Lima A, van Genderen ME, van Bommel J et al (2014) Nitroglycerin reverts clinical manifestations of poor peripheral perfusion in patients with circulatory shock. Crit Care Lond Engl 18:R126. doi:10.1186/cc13932
18. Lima A, Takala J (2014) Clinical significance of monitoring perfusion in non-vital organs. Intensive Care Med 40:1052–1054. doi:10.1007/s00134-014-3345-1
19. Xirouchaki N, Kondili E, Prinianakis G et al (2014) Impact of lung ultrasound on clinical decision making in critically ill patients. Intensive Care Med 40:57–65. doi:10.1007/s00134-013-3133-3
20. Bataille B, Riu B, Ferre F et al (2014) Integrated use of bedside lung ultrasound and echocardiography in acute respiratory failure: a prospective observational study in ICU. Chest 146:1586–1593. doi:10.1378/chest.14-0681
21. Gordon AC, Mason AJ, Perkins GD et al (2014) The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial. Crit Care Med 42:1325–1333. doi:10.1097/CCM.0000000000000212
22. Zhang Q, Dong G, Zhao X et al (2014) Prognostic significance of hypothalamic–pituitary–adrenal axis hormones in early sepsis: a study performed in the emergency department. Intensive Care Med 40:1499–1508. doi:10.1007/s00134-014-3468-4
23. Asfar P, Tuckermann J, Radermacher P (2014) Steroids and vasopressin in septic shock-brother and sister or just distant cousins? Crit Care Med 42:1531–1532. doi:10.1097/CCM.0000000000000262
24. Anantasit N, Boyd JH, Walley KR, Russell JA (2014) Serious adverse events associated with vasopressin and norepinephrine infusion in septic shock. Crit Care Med 42:1812–1820. doi:10.1097/CCM.0000000000000333
25. Douglas JJ, Tsang JLY, Walley KR (2014) Sepsis and the innate-like response. Intensive Care Med 40:249–251. doi:10.1007/s00134-013-3141-3
26. Bassetti M, Nicolau DP, Calandra T (2014) What’s new in antimicrobial use and resistance in critically ill patients? Intensive Care Med 40:422–426. doi:10.1007/s00134-013-3190-7
27. De Waele JJ, Lipman J, Akova M et al (2014) Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients. Intensive Care Med 40:1340–1351. doi:10.1007/s00134-014-3403-8
28. De Waele JJ, Carrette S, Carlier M et al (2014) Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial. Intensive Care Med 40:380–387. doi:10.1007/s00134-013-3187-2
29. Matthaiou DK, De Waele J, Dimopoulos G (2014) What is new in the use of aminoglycosides in critically ill patients? Intensive Care Med 40:1553–1555. doi:10.1007/s00134-014-3376-7
30. De Montmollin E, Bouadma L, Gault N et al (2014) Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen. Intensive Care Med 40:998–1005. doi:10.1007/s00134-014-3276-x
31. Montravers P, Dupont H, Bedos J-P et al (2014) Tigecycline use in critically ill patients: a multicentre prospective observational study in the intensive care setting. Intensive Care Med 40:988–997. doi:10.1007/s00134-014-3323-7
32. Kollef MH (2014) What can be expected from antimicrobial de-escalation in the critically ill? Intensive Care Med 40:92–95. doi:10.1007/s00134-013-3154-y
33. Garnacho-Montero J, Gutiérrez-Pizarraya A, Escoresca-Ortega A et al (2014) De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. Intensive Care Med 40:32–40. doi:10.1007/s00134-013-3077-7
34. Mokart D, Slehofer G, Lambert J et al (2014) De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study. Intensive Care Med 40:41–49. doi:10.1007/s00134-013-3148-9
35. Leone M, Bechis C, Baumstarck K et al (2014) De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial. Intensive Care Med 40:1399–1408. doi:10.1007/s00134-014-3411-8
36. León C, Ostrosky-Zeichner L, Schuster M (2014) What’s new in the clinical and diagnostic management of invasive candidiasis in critically ill patients. Intensive Care Med 40:808–819. doi:10.1007/s00134-014-3281-0
37. Lortholary O, Renaudat C, Sitbon K et al (2014) Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002–2010). Intensive Care Med 40:1303–1312. doi:10.1007/s00134-014-3408-3
38. Colombo AL, Guimarães T, Sukienik T et al (2014) Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9 year period. Intensive Care Med 40:1489–1498. doi:10.1007/s00134-014-3400-y
39. Maubon D, Garnaud C, Calandra T et al (2014) Resistance of Candida spp. to antifungal drugs in the ICU: where are we now? Intensive Care Med 40:1241–1255. doi:10.1007/s00134-014-3404-7
40. Albert M, Williamson D, Muscedere J et al (2014) Candida in the respiratory tract secretions of critically ill patients and the impact of antifungal treatment: a randomized placebo controlled pilot trial (CANTREAT study). Intensive Care Med 40:1313–1322. doi:10.1007/s00134-014-3352-2
41. Dimopoulos G, Kollef M, Blot S (2014) What is new in infection prevention in critical care in 2014? Intensive Care Med 40:1151–1154. doi:10.1007/s00134-014-3331-7
42. Vallés J, Martin-Loeches I, Torres A et al (2014) Epidemiology, antibiotic therapy and clinical outcomes of healthcare-associated pneumonia in critically ill patients: a Spanish cohort study. Intensive Care Med 40:572–581. doi:10.1007/s00134-014-3239-2
43. Berton DC, Kalil AC, Teixeira PJZ (2014) Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia. Cochrane Database Syst Rev 10:CD006482. doi: 10.1002/14651858.CD006482.pub4
44. Bos LDJ, Martin-Loeches I, Artigas A (2014) Innovations that could improve early recognition of ventilator-associated pneumonia. Intensive Care Med 40:1352–1354. doi:10.1007/s00134-014-3356-y
45. Bergan EH, Tura BR, Lamas CC (2014) Impact of improvement in preoperative oral health on nosocomial pneumonia in a group of cardiac surgery patients: a single arm prospective intervention study. Intensive Care Med 40:23–31. doi:10.1007/s00134-013-3049-y
46. Haverkate MR, Derde LPG, Brun-Buisson C et al (2014) Duration of colonization with antimicrobial-resistant bacteria after ICU discharge. Intensive Care Med 40:564–571. doi:10.1007/s00134-014-3225-8
47. Ekpe K, Novara A, Mainardi J-L et al (2014) Methicillin-resistant Staphylococcus aureus bloodstream infections are associated with a higher energy deficit than other ICU-acquired bacteremia. Intensive Care Med 40:1878–1887. doi:10.1007/s00134-014-3502-6
48. Harron K, Mok Q, Parslow R et al (2014) Risk of bloodstream infection in children admitted to paediatric intensive care units in England and Wales following emergency inter-hospital transfer. Intensive Care Med 40:1916–1923. doi:10.1007/s00134-014-3516-0
49. Tridente A, Clarke GM, Walden A et al (2014) Patients with faecal peritonitis admitted to European intensive care units: an epidemiological survey of the GenOSept cohort. Intensive Care Med 40:202–210. doi:10.1007/s00134-013-3158-7
50. Wolff M, Mourvillier B, Sonneville R, Timsit J-F (2014) My paper 10 years later: infective endocarditis in the intensive care unit. Intensive Care Med 40:1843–1852. doi:10.1007/s00134-014-3490-6
51. Bassetti M, Righi E, Ansaldi F et al (2014) A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality. Intensive Care Med 40:839–845. doi:10.1007/s00134-014-3310-z
52. Van der Geest PJ, Dieters EI, Rijnders B, Groeneveld J (2014) Safety and efficacy of amphotericin-B deoxycholate inhalation in critically ill patients with respiratory Candida spp. colonization: a retrospective analysis. BMC Infect Dis 14:575. doi:10.1186/s12879-014-0575-3
53. De Pascale G, Antonelli M (2014) Candida colonization of respiratory tract: to treat or not to treat, will we ever get an answer? Intensive Care Med 40:1381–1384. doi:10.1007/s00134-014-3364-y
54. Pittet D, Monod M, Suter PM et al (1994) Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220:751–758
55. Eggimann P, Pittet D (2014) Candida colonization index and subsequent infection in critically ill surgical patients: 20 years later. Intensive Care Med 40:1429–1448. doi:10.1007/s00134-014-3355-z
56. Koulenti D, Vogelaers D, Blot S (2014) What’s new in invasive pulmonary aspergillosis in the critically ill. Intensive Care Med 40:723–726. doi:10.1007/s00134-014-3254-3
57. Rieger C, Barlow S, Maschmeyer G (2014) What’s new in diagnosis and antimicrobial therapy of febrile neutropenic patients with lung infiltrates? Intensive Care Med 40:1549–1552. doi:10.1007/s00134-014-3368-7
58. Leung CHC, Gomersall CD (2014) Middle East respiratory syndrome. Intensive Care Med 40:1015–1017. doi:10.1007/s00134-014-3303-y
59. Tattevin P, Durante-Mangoni E, Massaquoi M (2014) Does this patient have Ebola virus disease? Intensive Care Med 40:1738–1741. doi:10.1007/s00134-014-3473-7
60. Parkes-Ratanshi R, Ssekabira U, Crozier I (2014) Ebola in West Africa: be aware and prepare. Intensive Care Med 40:1742–1745. doi:10.1007/s00134-014-3497-z
61. Fletcher TE, Fowler RA, Beeching NJ (2014) Understanding organ dysfunction in Ebola virus disease. Intensive Care Med 40:1936–1939. doi:10.1007/s00134-014-3515-1
62. Fenn B (2014) Coma alarm dreams on paediatric intensive care. Intensive Care Med 40:1568–1569. doi:10.1007/s00134-014-3280-1
63. Emeriaud G, Larouche A, Ducharme-Crevier L et al (2014) Evolution of inspiratory diaphragm activity in children over the course of the PICU stay. Intensive Care Med 40:1718–1726. doi:10.1007/s00134-014-3431-4
64. Kneyber MCJ, Jouvet PA, Rimensberger PC (2014) How to manage ventilation in pediatric acute respiratory distress syndrome? Intensive Care Med 40:1924–1926. doi:10.1007/s00134-014-3498-y
65. MacLaren G, Brown KL, Thiagarajan RR (2014) What’s new in paediatric extracorporeal membrane oxygenation? Intensive Care Med 40:1355–1358. doi:10.1007/s00134-014-3357-x
66. Madderom MJ, Reuser JJCM, Utens EMWJ et al (2013) Neurodevelopmental, educational and behavioral outcome at 8 years after neonatal ECMO: a nationwide multicenter study. Intensive Care Med 39:1584–1593. doi:10.1007/s00134-013-2973-1
67. Polito A, Barrett CS, Wypij D et al (2013) Neurologic complications in neonates supported with extracorporeal membrane oxygenation. An analysis of ELSO registry data. Intensive Care Med 39:1594–1601. doi:10.1007/s00134-013-2985-x
68. Brown KL, MacLaren G, Marino BS (2013) Looking beyond survival rates: neurological outcomes after extracorporeal life support. Intensive Care Med 39:1870–1872. doi:10.1007/s00134-013-3050-5
69. Essouri S, Laurent M, Chevret L et al (2014) Improved clinical and economic outcomes in severe bronchiolitis with pre-emptive nCPAP ventilatory strategy. Intensive Care Med 40:84–91. doi:10.1007/s00134-013-3129-z
70. Schlapbach LJ, Schaefer J, Brady A-M et al (2014) High-flow nasal cannula (HFNC) support in interhospital transport of critically ill children. Intensive Care Med 40:592–599. doi:10.1007/s00134-014-3226-7
71. Argent AC, Biban P (2014) What’s new on NIV in the PICU: does everyone in respiratory failure require endotracheal intubation? Intensive Care Med 40:880–884. doi:10.1007/s00134-014-3274-z
72. Wakeham MK, Kuhn EM, Lee KJ et al (2014) Use of tracheostomy in the PICU among patients requiring prolonged mechanical ventilation. Intensive Care Med 40:863–870. doi:10.1007/s00134-014-3298-4
73. Baranwal AK, Meena JP, Singhi SC, Muralidharan J (2014) Dexamethasone pretreatment for 24 vs. 6 h for prevention of postextubation airway obstruction in children: a randomized double-blind trial. Intensive Care Med 40:1285–1294. doi:10.1007/s00134-014-3358-9
74. Grunwell J (2014) Comments on Baranwal et al.: dexamethasone pretreatment for 24 h versus 6 h for prevention of postextubation airway obstruction in children. Intensive Care Med. doi:10.1007/s00134-014-3549-4
75. Prince NJ, Brown KL, Mebrahtu TF et al (2014) Weight-for-age distribution and case-mix adjusted outcomes of 14,307 paediatric intensive care admissions. Intensive Care Med 40:1132–1139. doi:10.1007/s00134-014-3381-x
76. Argent AC, Nadel S (2014) Big babies and big adults surprise us by their outcomes: why? Intensive Care Med 40:1772–1774. doi:10.1007/s00134-014-3439-9
77. Zinter MS, DuBois SG, Spicer A et al (2014) Pediatric cancer type predicts infection rate, need for critical care intervention, and mortality in the pediatric intensive care unit. Intensive Care Med 40:1536–1544. doi:10.1007/s00134-014-3389-2
78. Peters MJ, Agbeko RS (2014) Optimism and no longer foolishness? Haematology/oncology and the PICU. Intensive Care Med 40:1589–1591. doi:10.1007/s00134-014-3478-2